Aether Bio
company
About
Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Artificial Intelligence,Machine Learning,Medical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are more cheap and sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Aether Bio has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Nov 2, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 2, 2021 | Seed | — | 1 | — | — | Detail |
| Jul 1, 2019 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Aether Bio is funded by 2 investors.
Gaingels
and NJF Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Gaingels
|
— | Seed |
NJF Capital
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
